491 results on '"Sandhaus, Robert"'
Search Results
52. sj-pdf-1-taj-10.1177_2040622320974875 – Supplemental material for Foreword
53. Pulmonary Function in Osteogenesis Imperfecta
54. List of Contributors
55. Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency
56. Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
57. Alpha1-antitrypsin deficiency
58. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
59. Foreword
60. Prospective Impact of Illness Uncertainty on Outcomes in Chronic Lung Disease
61. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
62. Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency
63. Gene Therapy Meets Stem Cells
64. α1-Antitrypsin Deficiency
65. Contributors
66. Clinical considerations in individuals with α1-antitrypsin PI*SZ genotype
67. Home-Based Multicomponent Intervention Increases Exercise Activity and Improves Body Mass Index: Results of a 5-Year Randomized Trial Among Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
68. Alpha-1 Antitrypsin Deficiency: Whom to Test, Whom to Treat?
69. Delay in Diagnosis of α1-Antitrypsin Deficiency: A Continuing Problem
70. Trends in the Diagnosis of Symptomatic Patients With α1-Antitrypsin Deficiency Between 1968 and 2003
71. Response
72. α1-Antitrypsin Augmentation Therapy for PI*MZ Heterozygotes*: A Cautionary Note
73. Clinical characteristics of subjects with symptoms of (alpha)1-antitrypsin deficiency older than 60 years
74. Influenza Vaccination in Subjects With α1-Antitrypsin Deficiency*
75. IL10 Polymorphisms Are Associated with Airflow Obstruction in Severe α1-Antitrypsin Deficiency
76. An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiency
77. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency
78. Characterization of differences in isoelectric focusing behavior of α1-proteinase inhibitor products
79. Results of a Survey of Patients with Alpha-1 Antitrypsin Deficiency
80. Delay in diagnosis of [[alpha].sub.1]-antitrypsin deficiency *: a continuing problem
81. Trends in the diagnosis of symptomatic patients with [[alpha].sub.1]-antitrypsin deficiency between 1968 and 2003 *
82. Augmentation Therapy With α1-Antitrypsin*: Patterns of Use and Adverse Events
83. α1-Antitrypsin Deficiency Therapy: Pieces of the Puzzle
84. Occupational Exposure Risks in Individuals with PI*Z α1-Antitrypsin Deficiency
85. Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency
86. Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease
87. Respiratory health impacts quality of life for adults with OI
88. Scoliosis and cardiopulmonary outcomes in adults with osteogenesis imperfecta: a pilot study
89. Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria
90. Lectin Complement Pathway in Emphysema
91. Costs of Medical Care Among Augmentation Therapy Users and Non-Users with Alpha-1 Antitrypsin Deficiency in the United States
92. Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet’s Disease Management Program
93. Alpha1-Antitrypsin Augmentation Therapy
94. Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency.
95. Chapter 1 - Historical Perspective
96. Bioequivalence of a Liquid Formulation of Alpha1-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha1-PI) in Alpha1-Antitrypsin Deficiency
97. Medical Costs of Alpha-1 Antitrypsin Deficiency: Evidence From Real-World Claims Data
98. The Relationship Between Changes in CT-Measured Lung Density and Lung Volume in Severe Alpha-1 Antitrypsin Deficiency: Post-Hoc Analysis of the RAPID Trial
99. Effect of Alpha-1 Proteinase Inhibitor (A 1-PI) Therapy on Changes in Regional Lung Density: A Post-Hoc Analysis of the RAPID Trial
100. Alpha-1 antitrypsin (A1-PI) treatment slows emphysema progression independent of baseline FEV1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.